St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Muscular dystrophies and myopathies are conditions that make muscles weak and smaller over time. It becomes harder to move and do everyday activities as the muscles get weaker.
These conditions are often caused by changes (mutations) in genes. Genes tell the body to make proteins that help muscles work. If a gene changes, the body may not make the protein correctly, or it might stop making the protein. This can lead to weak muscles. Most of the time, the gene changes are inherited from a parent. But sometimes, they happen for the first time in the child.
Muscular dystrophies are a type of myopathy. “Myopathy” is a word for any muscle disease. “Muscular dystrophy” refers to genetic muscle diseases that get worse over time. Not all myopathies are genetic. Some are caused by problems like inflammation or infection.
There are many types of muscular dystrophies and myopathies. Some start in young children. Others start later in life.
Learn about the Muscle Disorders Clinic at St. Jude Children’s Research Hospital.
The main symptom of a muscular dystrophy or myopathy is muscle weakness.
Depending on the type, weakness may stay the same or slowly get worse. Symptoms can be different depending on when they start.
Common symptoms include:
Each child’s symptoms and how quickly they change can be different.
Types of muscular dystrophies and myopathies studied at St. Jude Children’s Research Hospital include:
DMD is the most common type of muscular dystrophy. It affects mostly boys. Symptoms usually start between ages 2 and 5.
Children with DMD often have trouble walking or climbing stairs. Over time, they may need a wheelchair. DMD also affects the heart and breathing muscles. It is important to see the health care team often.
DMD occurs in about 1 in 3,500 to 5,000 babies from all ethnic groups.
Limb-girdle muscular dystrophies (LGMDs) are rare muscle diseases that affect both boys and girls. These conditions usually affect muscles around the hips and shoulders first. These are called the “limb girdle” areas.
Some types of LGMD start in childhood. Others start later in life.
People with LGMD may have mild symptoms. Others may have more serious problems with walking, lifting, or using their arms. Some people may develop disabilities.
LGMD is less common than DMD. It affects fewer than 2 out of every 100,000 people. The numbers vary by type and area of the world.
Right now, there is no cure for muscular dystrophy. Some genetic treatments are available for DMD, and more are being tested for some of these disorders.
Your child’s care team will work to manage symptoms and help your child maintain function.
St. Jude is working to better understand rare, catastrophic genetic neurological disorders in children. Our goal is to change how these disorders are treated. The Center for Experimental Neurotherapeutics (CENT) was started at St. Jude as part of the Pediatric Translational Neuroscience Initiative (PTNI) to focus on these neurological disorders.
Children with muscular dystrophies and myopathies who are accepted at St. Jude may take part in clinical research or clinical trials, as they become available. These studies help scientists learn more and develop new treatments.
There are no open clinical trials for muscular dystrophies at this time.
Browse open clinical trialsPatients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334